Trial Profile
A Prospective Observational Study Reviewing the Incidence of Nail Changes in Breast Cancer Patients Receiving Docetaxel- Based Chemotherapy.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Jan 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Antineoplastics
- Indications Early breast cancer
- Focus Adverse reactions
- 23 Jun 2009 New trial record